LYELL
Live / Registered — Registered (as of 31 Oct 2023)
What this means for you
Registered since 31 Oct 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88228691
- Registration number
- 7207833
- Mark type
- Stylized text
- Filed
- 13 Dec 2018
- Published for opposition
- 30 Jun 2020
- Registered
- 31 Oct 2023
- Attorney of record
- Christina L. Martini
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and drugs for the treatment of cancer; cells for medical or clinical purposes; pharmaceutical preparations for cell therapy for medical or clinical purposes; pharmaceutical preparations for gene therapy for medical or clinical purposes; kits comprised of cells and pharmaceutical preparations for medical or clinical purposes
- Class 042 — Scientific and technological services: Pharmaceutical research and development; development of pharmaceutical preparations and drugs; development of pharmaceutical preparations and drugs for the treatment of cancer; development of pharmaceutical preparations and drugs in the field of immunotherapy; development of pharmaceutical preparations and drugs in the field of cell therapy; scientific research and development; medical and scientific research
Owner
- Lyell Immunopharma, Inc., South San Francisco, CA, US
- Lyell Immunopharma, Inc., South San Francisco, CA, US
- Lyell Immunopharma, Inc., Seattle, WA, US
Prosecution history
- 31 Oct 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 Oct 2023 — REGISTERED-PRINCIPAL REGISTER
- 28 Sept 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Sept 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 19 Aug 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Aug 2023 — USE AMENDMENT FILED
- 18 Aug 2023 — TEAS STATEMENT OF USE RECEIVED
- 15 Feb 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Feb 2023 — SOU EXTENSION 5 GRANTED
- 27 Jan 2023 — SOU EXTENSION 5 FILED
- 13 Feb 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 27 Jan 2023 — SOU TEAS EXTENSION RECEIVED
- 30 Jul 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jul 2022 — SOU EXTENSION 4 GRANTED
- 28 Jul 2022 — SOU EXTENSION 4 FILED